Products - Organ and tissue transplantation | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 28 products

Date | Title

Maribavir for treating refractory cytomegalovirus infection after transplant (TA860)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
18 January 2023
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease (TA809)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
20 July 2022
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant (IPG695)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 May 2021
Ex-situ machine perfusion for extracorporeal preservation of livers for transplantation (IPG636)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
16 January 2019
Robot-assisted kidney transplant (IPG609)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 April 2018
Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure (IPG602)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
20 December 2017
Immunosuppressive therapy for kidney transplant in adults (TA481)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
11 October 2017
Immunosuppressive therapy for kidney transplant in children and young people (TA482)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
11 October 2017
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation (CG135)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
21 December 2016
Published:
12 December 2011
Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death (IPG549)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 February 2016
Living-donor liver transplantation (IPG535)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 November 2015
Blood transfusion (NG24)
Product type:
Guidance
Programme:
NICE guideline
Published:
18 November 2015
Everolimus for preventing organ rejection in liver transplantation (TA348)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
22 July 2015
Hand allotransplantation (IPG383)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 March 2011
Corneal endothelial transplantation (IPG304)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 June 2009
Machine perfusion systems and cold static storage of kidneys from deceased donors (TA165)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
28 January 2009
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (IPG274)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 September 2008
Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery (IPG177)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 June 2006
Living-donor lung transplantation for end-stage lung disease (IPG170)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 May 2006
Laparoscopic live donor simple nephrectomy (IPG57)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 May 2004
OrganOx metra for liver transplant (MIB275)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
14 September 2021
Hemosep for cell salvage (MIB103)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
3 May 2017
OCS Heart system for heart transplant (MIB86)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
29 November 2016
Blood transfusion (QS138)
Product type:
Quality standard
Published:
15 December 2016
OrganOx metra for liver transplant [ID5116]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Letermovir for preventing cytomegalovirus infection after a kidney transplant [ID6166]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
In-situ Normothermic Regional Perfusion system for DCD donors - liver
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
TBC